Answer a few questions using Lilly Trial Match to find which Lilly trials may be the best fit for you or your loved one.
Answer a few questions using Lilly Trial Match to find which Lilly trials may be the best fit for you or your loved one.

Find a Lilly Clinical Trial

13  Enrolling
22  Total Trials
Pinned
Conditions: Rheumatoid Arthritis
Drugs: LY3871801
Age
≥18 years
Phase
II
Pinned
Conditions: Obesity, Overweight and Osteoarthritis of the Knee
Trial Name
TRIUMPH-4
Drugs: Retatrutide
Age
≥18 years
Phase
III
Conditions: Juvenile Idiopathic Arthritis
Trial Name
JUVE-X
Drugs: Baricitinib
Age
1 year - 18 years
Phase
III
Conditions: Arthritis
Drugs: Ixekizumab, Adalimumab
Age
2 - 17 years
Phase
III
Conditions: Plaque Psoriasis
Drugs: LY3972406
Age
18 - 75 years
Phase
II
Conditions: Systemic Juvenile Idiopathic Arthritis
Drugs: Baricitinib
Age
1 year - 17 years
Phase
III
Conditions: Hidradenitis Suppurativa
Drugs: Eltrekibart
Age
18 - 75 years
Phase
II
Conditions: Alopecia Areata (hair loss)
Trial Name
BRAVE-AA-PEDS
Drugs: baricitinib
Age
6 - 17 years
Phase
III
Conditions: Atopic Dermatitis (Eczema)
Drugs: Ucenprubart
Age
18 - 70 years
Phase
II
Conditions: Atopic Dermatitis (Eczema )
Trial Name
ADmirable
Drugs: Lebrikizumab
Age
≥12 years
Phase
III
Conditions: Atopic Dermatitis (Eczema)
Trial Name
ADorable-1
Drugs: Lebrikizumab, Topical corticosteroid
Age
6 months - 17 years
Phase
III
Conditions: Alopecia Areata (hair loss)
Trial Name
BRAVE-AA1
Drugs: Baricitinib
Age
18 - 70 years
Phase
III
Conditions: Rheumatoid Arthritis
Trial Name
RA-BRANCH
Drugs: Baricitinib, TNF Inhibitor
Age
≥18 years
Phase
IV

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.
2  Not Yet Enrolling
22  Total Trials
Conditions: Atopic Dermatitis (Eczema)
Trial Name
ADorable-2
Drugs: Lebrikizumab
Age
6 months - 18 years
Phase
III
Conditions: Multiple Sclerosis
Drugs: Pirtobruitinib
Age
18 - 55 years
Phase
II
7 
Completed Enrollment
22  Total Trials
Conditions: Uveitis
Drugs: Baricitinib, Adalimumab
Age
2 - 17 years
Phase
III
Conditions: Rheumatoid Arthritis
Trial Name
RESOLUTION-1
Drugs: Peresolimab
Age
≥18 years
Phase
II
Conditions: Atopic Dermatitis (Eczema)
Trial Name
ADapt
Drugs: Lebrikizumab
Age
≥12 years
Phase
III
Conditions: Aicardi Goutieres Syndrome (AGS)
Drugs: Baricitinib
Age
≥6 months
Phase
III
Conditions: Alopecia Areata (Hair Loss)
Trial Name
BRAVE-AA2
Drugs: Baricitinib, Placebo
Age
18 - 70 years
Phase
III
Conditions: Atopic Dermatitis (Eczema)
Trial Name
BREEZE-AD-PEDS
Drugs: Baricitinib, Placebo
Age
2 - 17 years
Phase
III
Conditions: Rheumatoid Arthritis
Trial Name
RA-BRIDGE
Drugs: Baricitinib, TNF Inhibitor
Age
≥18 years
Phase
IV